Advanced biologic technologies. Distinct clinical options.
Cellxo™
Explore the Cellxo™ portfolio from EMC Pharma—biologic technologies developed for professional use and supported by rigorous sourcing, testing, and quality standards.
Explore the Cellxo™ Portfolio Product Information
EXPLORE THE PORTFOLIO

Distinct technologies. Purpose-built options.

Compare source, technology, extracellular vesicle count and format across the EMC Pharma regenerative biologics portfolio.

Cellxo™ 25B

Amniotic Fluid Derived

25 Billion Exosomes
2 mL

View / Order

Cellxo™ 50B

Amniotic Fluid Derived

50 Billion Exosomes
2 mL

View / Order

Cellxo™ Wharton’s Jelly Matrix

Wharton’s Jelly Matrix

50 Billion Exosomes
2 mL

View / Order
Additional Technology

PRP

Platelet-Rich Plasma

An autologous platelet-derived extracellular-vesicle technology beginning with the patient’s own platelet-rich plasma.

Extracellular Vesicles · 2 mL

Contact Us
UNDERSTANDING THE TECHNOLOGIES

Different sources. Different formats. Different clinical considerations.

The Cellxo™ portfolio brings together distinct regenerative biologic technologies. Understanding the source and format of each option helps clinicians evaluate which technology best aligns with their intended use.

01

Amniotic Fluid Derived

Cellxo™ 25B & 50B

Acellular, amniotic-fluid-derived products available in two extracellular-vesicle concentrations.

Source Amniotic fluid
Format Acellular
Options 25B / 2 mL  ·  50B / 2 mL
02

Wharton’s Jelly Matrix

Cellxo™ Wharton’s Jelly Matrix

A distinct acellular matrix-based option combining Wharton’s Jelly-derived matrix components with extracellular vesicles.

Source Wharton’s Jelly
Format Acellular matrix
Option 50B / 2 mL
03

PRP

Platelet-Rich Plasma
Patient-Derived

An autologous platelet-derived extracellular-vesicle technology beginning with the patient’s own platelet-rich plasma.

Source Patient-derived PRP
Format Autologous
Technology Extracellular vesicles
Product selection should be based on clinician judgment, intended use, product information and applicable regulatory considerations.